{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:18:59Z","timestamp":1791253139242,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,8,30]],"date-time":"2006-08-30T00:00:00Z","timestamp":1156896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,8,30]],"date-time":"2006-08-30T00:00:00Z","timestamp":1156896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s11064-006-9110-2","type":"journal-article","created":{"date-parts":[[2006,8,29]],"date-time":"2006-08-29T13:47:02Z","timestamp":1156859222000},"page":"1103-1109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Oxidative Stress in Skin Fibroblasts Cultures of Patients with Huntington\u2019s Disease"],"prefix":"10.1007","volume":"31","author":[{"given":"Pilar","family":"del Hoyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Garc\u00eda-Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"de Bustos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortensia","family":"Alonso-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix Javier","family":"Jim\u00e9nez-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,8,30]]},"reference":[{"key":"9110_CR1","first-page":"477","volume-title":"Movement disorders: neurologic principles and practice","author":"JF Gusella","year":"1997","unstructured":"Gusella JF, MacDonald ME (1997) Genetics and molecular biology of Huntington\u2019s disease. In: Watts RL, Koller WC (eds) Movement disorders: neurologic principles and practice. McGraw-Hill, New-York, pp 477\u2013490"},{"key":"9110_CR2","first-page":"725","volume-title":"Tratado de los trastornos del movimiento","author":"M Calopa-Garriga","year":"1998","unstructured":"Calopa-Garriga M, Gen\u00eds-Battle D, S\u00e1nchez-D\u00edaz A (1998) Enfermedad de Huntington. In: Jim\u00e9nez-Jim\u00e9nez FJ, Luquin MR, Molina JA (eds) Tratado de los trastornos del movimiento. IM&C, Madrid, pp 725\u2013760"},{"key":"9110_CR3","first-page":"212","volume-title":"Parkinson\u2019s disease and movement disorders","author":"KM Biglan","year":"2002","unstructured":"Biglan KM, Shoulson I (2002) Huntington\u2019s disease. In: Jankovic JJ, Tolosa E (eds) Parkinson\u2019s disease and movement disorders, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 212\u2013227","edition":"4"},{"key":"9110_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne SE, Bowling AC, MacGarvey U et al (1997) Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol 41:646\u2013653","journal-title":"Ann Neurol"},{"key":"9110_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","volume":"9","author":"SE Browne","year":"1999","unstructured":"Browne SE, Ferrante RJ, Beal MF (1999) Oxidative stress in Huntington\u2019s disease. Brain Pathol 9:147\u2013163","journal-title":"Brain Pathol"},{"key":"9110_CR6","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1046\/j.1471-4159.2001.00689.x","volume":"79","author":"MB Bogdanov","year":"2001","unstructured":"Bogdanov MB, Andreassen OA, Dedeoglu A et al (2001) Increased oxidative damage in a transgenic mouse model of Huntingtons\u2019s disease. J Neurochem 79:1246\u20131249","journal-title":"J Neurochem"},{"key":"9110_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1023\/B:NERE.0000018843.83770.4b","volume":"29","author":"F P\u00e9rez-Severiano","year":"2004","unstructured":"P\u00e9rez-Severiano F, Santamar\u00eda A, Pedraza-Chaverri J et al (2004) Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington\u2019s disease mutation. Neurochem Res 29:729\u2013733","journal-title":"Neurochem Res"},{"key":"9110_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00001756-199301000-00019","volume":"4","author":"SR Rossi","year":"1993","unstructured":"Rossi SR, Simpson JR, Isacson O (1993) Age dependence of striatal neuronal death caused by mitochondrial dysfunction. Neuroreport 4:73\u201376","journal-title":"Neuroreport"},{"key":"9110_CR9","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG et al (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181\u20134192","journal-title":"J Neurosci"},{"key":"9110_CR10","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","volume":"92","author":"E Brouillet","year":"1995","unstructured":"Brouillet E, Hantraye P, Ferrante RJ et al (1995) Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci USA 92:7105\u20137109","journal-title":"Proc Natl Acad Sci USA"},{"key":"9110_CR11","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1046\/j.1471-4159.2000.0751709.x","volume":"75","author":"MA Fontaine","year":"2000","unstructured":"Fontaine MA, Geddes JW, Banks A et al (2000) Effect of exogenous and endogenous antioxidants on 3-nitropropionic acid-induced in vivo oxidative stress and striatal lesions: insights into Huntington\u2019s disease. J Neurochem 75:1709\u20131715","journal-title":"J Neurochem"},{"key":"9110_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1471-4159.2006.03724.x","volume":"97","author":"I T\u00fanez","year":"2006","unstructured":"T\u00fanez I, Drucker-Colin R, Jimena I et al (2006) Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington\u2019s disease. J Neurochem 97:619\u2013630","journal-title":"J Neurochem"},{"key":"9110_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-079X.2004.00163.x","volume":"37","author":"I T\u00fanez","year":"2004","unstructured":"T\u00fanez I, Montilla P, Del Carmen-Mu\u00f1oz M et al (2004) Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington\u2019s disease. J Pineal Res 37:252\u2013256","journal-title":"J Pineal Res"},{"key":"9110_CR14","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","volume":"61","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins B et al (1993) Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem 61:1147\u20131150","journal-title":"J Neurochem"},{"key":"9110_CR15","doi-asserted-by":"crossref","unstructured":"Schapira AHV (1994) Mitochondrial dysfunction in neurodegenerative disorders and aging. In: Schapira AHV, DiMauro S (eds) Mitochondrial disorders in neurology. Butterworth-Heinemann Ltd., Oxford, 227\u2013244","DOI":"10.1016\/B978-0-7506-0585-4.50017-4"},{"key":"9110_CR16","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Ort\u00ed-Pareja M, Molina JA (1998) Alteraciones mitocondriales en las enfermedades neurodegenerativas. In: Jim\u00e9nez-Jim\u00e9nez FJ, Molina JA, Arenas J (eds) Enfermedades mitocondriales. Rev. Neurol. 26 Suppl 1:S 112-S 117","DOI":"10.33588\/rn.26S1.98190"},{"key":"9110_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02834296","volume":"4","author":"SJ Kish","year":"1986","unstructured":"Kish SJ, Morito CL, Hornykiewicz O (1986) Brain glutathione peroxidase in neurodegenerative disorders. Neurochem Pathol 4:23\u201328","journal-title":"Neurochem Pathol"},{"key":"9110_CR18","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1007\/BF01937382","volume":"32","author":"TC Loomis","year":"1976","unstructured":"Loomis TC, Yee G, Stahl WL (1976) Regional and subcellular distribution of superoxide dismutase in brain. Experientia 32:1364\u20131376","journal-title":"Experientia"},{"key":"9110_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.20-01-00001.2000","volume":"20","author":"P Klivenyi","year":"2000","unstructured":"Klivenyi P, Andreassen OA, Ferrante RJ et al (2000) Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurosci 20:1\u20137","journal-title":"J Neurosci"},{"key":"9110_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1023\/A:1010911417383","volume":"26","author":"A Santamar\u00eda","year":"2001","unstructured":"Santamar\u00eda A, P\u00e9rez-Severiano F, Rodr\u00edguez-Mart\u00ednez E et al (2001) Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington\u2019s disease. Neurochem Res 26:419\u2013424","journal-title":"Neurochem Res"},{"key":"9110_CR21","doi-asserted-by":"publisher","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","volume":"96","author":"O Hansson","year":"1999","unstructured":"Hansson O, Petersen A, Leist M et al (1999) Transgenic mice expressing a Huntington\u2019s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc Natl Acad Sci USA 96:8727\u20138732","journal-title":"Proc Natl Acad Sci USA"},{"key":"9110_CR22","first-page":"261","volume":"42","author":"L Ernster","year":"1995","unstructured":"Ernster L, Dallner G (1995) Biochemical, physiological and medical aspects of ubiquinone function. Ann Neurol 42:261\u2013264","journal-title":"Ann Neurol"},{"key":"9110_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ana.410420221","volume":"42","author":"CQ Shults","year":"1997","unstructured":"Shults CQ, Haas RH, Passov D et al (1997) Coenzyme Q10 levels correlate with the activities of complexes I and II\/III mitochondria from parkinsonian and nonparkinsonian patients. Ann Neurol 42:261\u2013264","journal-title":"Ann Neurol"},{"key":"9110_CR24","first-page":"111","volume":"68","author":"J Andrich","year":"2004","unstructured":"Andrich J, Saft C, Gerlach M et al (2004) Coenzyme Q10 serum levels in Huntington\u2019s disease. J Neural Transm 68:111\u2013116","journal-title":"J Neural Transm"},{"key":"9110_CR25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/clinchem\/39.4.667","volume":"39","author":"N Barroso","year":"1993","unstructured":"Barroso N, Campos Y, Huertas R et al (1993) Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease. Clin Chem 39:667\u2013669","journal-title":"Clin Chem"},{"key":"9110_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2728(90)90118-N","volume":"101","author":"X Zheng","year":"1990","unstructured":"Zheng X, Shoffner JM, Voljavec AS et al (1990) Evaluation of procedures for assaying oxidative phosphorylation enzyme activities in mitochondrial myopathy muscle biopsies. Biochim Biophys Acta 101:1\u201310","journal-title":"Biochim Biophys Acta"},{"key":"9110_CR27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the Folin phenlo reagent. J Biol Chem 193:265\u2013271","journal-title":"J Biol Chem"},{"key":"9110_CR28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0076-6879(84)05015-1","volume":"105","author":"L Floh\u00e9","year":"1984","unstructured":"Floh\u00e9 L, G\u00fcnzler W (1984) Assays of glutathione peroxidase. Methods Enzymol 105:114\u2013121","journal-title":"Methods Enzymol"},{"key":"9110_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121\u2013126","journal-title":"Methods Enzymol"},{"key":"9110_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0003-2697(89)90192-9","volume":"179","author":"DR Spitz","year":"1989","unstructured":"Spitz DR, Oberley LW (1989) An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 179:8\u201318","journal-title":"Anal Biochem"},{"key":"9110_CR31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-2275(20)37636-7","volume":"37","author":"J Langedijk","year":"1996","unstructured":"Langedijk J, Ubbink JB, Vermaak WJH (1996) Measurement of the ratio between the reduced and oxidized forms of coenzyme Q10 in human plasma as a possible marker of oxidative stress. J Lipid Res 37:67\u201375","journal-title":"J Lipid Res"},{"key":"9110_CR32","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","volume":"44","author":"WA Brennan Jr","year":"1985","unstructured":"Brennan Jr WA, Bird ED, Aprille JR (1985) Regional mitochondrial respiratory activity in Huntington\u2019s disease brain. J Neurochem 44:1948\u20131950","journal-title":"J Neurochem"},{"key":"9110_CR33","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0140-6736(90)92242-A","volume":"336","author":"VM Mann","year":"1990","unstructured":"Mann VM, Cooper JM, Javoy-Agid Y et al (1990) Mitochondrial function and parental sex effect in Huntington\u2019s disease. Lancet 336:749","journal-title":"Lancet"},{"key":"9110_CR34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M, Gash MT, Mann VM et al (1996) Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol 39:385\u2013389","journal-title":"Ann Neurol"},{"key":"9110_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","volume":"45","author":"SJ Tabrizi","year":"1999","unstructured":"Tabrizi SJ, Cleeter MW, Xuereb J et al (1999) Biochemical abnormalities and excitotoxicity in Huntington\u2019s disease brain. Ann Neurol 45:25\u201332","journal-title":"Ann Neurol"},{"key":"9110_CR36","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1212\/WNL.40.8.1231","volume":"40","author":"WD Parker Jr","year":"1990","unstructured":"Parker Jr WD, Boyson SJ, Luder AS, Parks JK et al (1990) Evidence for a defect in NADP: ubiquinone oxidoreductase (complex I) in Huntington\u2019s disease. Neurology 40:1231\u20131234","journal-title":"Neurology"},{"key":"9110_CR37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ana.410430321","volume":"43","author":"J Arenas","year":"1998","unstructured":"Arenas J, Campos Y, Ribacoba R et al (1998) Complex I defect in muscle from patients with Huntington\u2019s disease. Ann Neurol 43:397\u2013400","journal-title":"Ann Neurol"},{"key":"9110_CR38","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst CA, Leavitt BR et al (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5:731\u2013736","journal-title":"Nat Neurosci"},{"key":"9110_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.410410206","volume":"41","author":"WJ Koroshetz","year":"1997","unstructured":"Koroshetz WJ, Jenkins BG, Rosen BR et al (1997) Energy metabolism defects in Huntington\u2019s disease and effects of coenzyme Q10. Ann Neurol 41:160\u2013165","journal-title":"Ann Neurol"},{"key":"9110_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","volume":"48","author":"R Lodi","year":"2000","unstructured":"Lodi R, Schapira AH, Manners D et al (2000) Abnormal in vivo skeletal muscle energy metabolism in Huntington\u2019s disease and dentatorubropallidoluysian atrophy. Ann Neurol 48:72\u201376","journal-title":"Ann Neurol"},{"key":"9110_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3940(01)02326-6","volume":"315","author":"G Schilling","year":"2001","unstructured":"Schilling G, Coonfield ML, Ross CA et al (2001) Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington\u2019s disease transgenic mouse model. Neurosci Lett 315:149\u2013153","journal-title":"Neurosci Lett"},{"key":"9110_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.expneurol.2004.01.003","volume":"187","author":"G Schilling","year":"2004","unstructured":"Schilling G, Savonenko AV, Coonfield ML et al (2004) Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice. Exp Neurol 187:137\u2013149","journal-title":"Exp Neurol"},{"key":"9110_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/mds.870110317","volume":"11","author":"A Feigin","year":"1996","unstructured":"Feigin A, Kieburtz K, Como P et al (1996) Assessment of coenzyme Q10 tolerability in Huntington\u2019s disease. Mov Disord 11:321\u2013323","journal-title":"Mov Disord"},{"key":"9110_CR44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/WNL.57.3.397","volume":"57","author":"Huntington Study Group","year":"2001","unstructured":"Huntington Study Group (2001) A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington\u2019s disease. Neurology 57:397\u2013404","journal-title":"Neurology"},{"key":"9110_CR45","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1081\/DMR-200033488","volume":"36","author":"R Kahl","year":"2004","unstructured":"Kahl R, Kampkotter A, Watjen W et al (2004) Antioxidant enzymes and apoptosis. Drug Metab Rev 36:747\u2013762","journal-title":"Drug Metab Rev"},{"key":"9110_CR46","doi-asserted-by":"publisher","first-page":"12553","DOI":"10.1073\/pnas.93.22.12553","volume":"93","author":"S Okuda","year":"1996","unstructured":"Okuda S, Nishiyama N, Saito H et al (1996) Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine. Proc Natl Acad Sci USA 93:12553\u201312558","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-006-9110-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-006-9110-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-006-9110-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-006-9110-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T18:11:21Z","timestamp":1683569481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-006-9110-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,30]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["9110"],"URL":"https:\/\/doi.org\/10.1007\/s11064-006-9110-2","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,30]]},"assertion":[{"value":"30 June 2006","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2006","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}